Merilog, classified as a rapid-acting human insulin analog, is designed to reduce mealtime blood sugar spikes, improving ...

A Sanofi subsidiary has claimed FDA approval for the first biosimilar of Novo Nordisk's Novolog, an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart.

Objectives: The prevalence, causes, and consequences of nocturnal hypoglycemia as well as detection and prevention strategies are reviewed, including the use of long-acting insulin analogs ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

TI has a more rapid onset of action than rapid-acting insulin analogs. In this study, adults with type 1 diabetes initiated a regimen of TI plus insulin degludec after completing the usual-care ...

Beck and colleagues from the JAEB Center for Health Research, Tampa, Florida, USA, highlight the rapid onset of action of inhaled Technosphere Insulin (TI, Afrezza) compare ...

"In fact, approximately 80% of people in non-high deductible commercial health plans pay $50 or less per month for a prescription of one of our insulin analogs. For those patients who do pay the ...

The 26-week, open-label clinical trial randomized 230 pediatric subjects to one of two groups: Afrezza or multiple daily injections (MDI) of rapid acting insulin analog (RAA) in combination with ...

studies conducted with non-commercially available analog formulations, or trials conducted with insulin preparations that are no longer commercially available.